Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | PRKCI | P41743 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186697 | 0.86 | LIPG (0.47) | LIPG | |
| SCHEMBL376413 | 0.84 | LIPG (0.55) | LIPGPPARGPPARA | |
| SCHEMBL8698489 | 0.84 | TAAR1 (0.35) | GABRA1GABRB2DAOMAPTNPSR1 | |
| SCHEMBL11226283 | 0.82 | LIPG (0.58) | LIPGPPARGPPARA | |
| SCHEMBL660368 | 0.82 | LIPG (0.58) | LIPGPPARGPPARA | |
| SCHEMBL2679239 | 0.82 | LIPG (0.58) | LIPGPPARGPPARA | |
| SCHEMBL4325574 | 0.82 | LIPG (0.58) | LIPGPPARGPPARA | |
| SCHEMBL2678792 | 0.82 | LIPG (0.58) | LIPGPPARGPPARA | |
| SCHEMBL395989 | 0.82 | LIPG (0.58) | LIPGPPARGPPARA | |
| SCHEMBL659946 | 0.82 | LIPG (0.58) | LIPGPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1518 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116410239-A | Heteroatom-containing metallocene compound and preparation method and application thereof | 惠生(中国)投资有限公司 | 2023-07-11 | — | — | CN | claimed |
| CN-110818545-B | Method for preparing substituted aryl ketone by ketone arylation | 上海化工研究院有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-110922286-B | Asymmetric aryl substituted fulvene compound and preparation method and application thereof | 上海化工研究院有限公司 | 2022-08-16 | — | — | CN | claimed |
| CN-107963982-B | Polyisocyanate composition and isocyanate polymer composition | 旭化成株式会社 | 2021-11-12 | — | — | CN | claimed |
| WO-2021122698-A1 | TEXTILE COATED WITH MALODOR REDUCING POLYMERS | BASF SE (DE) | 2021-06-24 | — | — | WO | claimed |
| WO-2021122709-A1 | TEXTILE COATED WITH MALODOR REDUCING POLYMERS | BASF SE (DE) | 2021-06-24 | — | — | WO | claimed |
| WO-2021122692-A1 | TEXTILE COATED WITH MALODOR REDUCING POLYMERS | BASF SE (DE) | 2021-06-24 | — | — | WO | claimed |
| US-10745372-B2 | Compound, resin, material for forming underlayer film for lithography, underlayer film for lithography, pattern forming method, and purification method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-08-18 | — | — | US | claimed |
| CN-110922286-A | Asymmetric aryl substituted fulvene compound and preparation method and application thereof | 上海化工研究院有限公司 | 2020-03-27 | — | — | CN | claimed |
| CN-110818545-A | Method for preparing substituted aryl ketone by ketone arylation | 上海化工研究院有限公司 | 2020-02-21 | — | — | CN | claimed |
| US-20050215526-A1 | Melanin concentrating hormone receptor antagonist | AMGEN, INC. | 2005-09-29 | — | — | US | claimed |
| US-6943225-B2 | Multinuclear metallocene catalyst | HONAM PETROCHEMICAL CORPORATION (KR) | 2005-09-13 | — | — | US | claimed |
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-05-19 | — | — | US | claimed |
| WO-2005021558-A2 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON, INC. (US) | 2005-03-10 | — | — | WO | claimed |
| WO-2005019167-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN, INC. (US) | 2005-03-03 | — | — | WO | claimed |
| WO-2004076502-A1 | SUPPORTED MULTINUCLEAR METALLOCENE CATALYST FOR OLEFIN POLYMERIZATION AND METHOD FOR PREPARING THE SAME | HONAM PETROCHEMICAL CORPORATION (KR) | 2004-09-10 | — | — | WO | claimed |
| US-20040072677-A1 | Multinuclear metallocene catalyst | HONAM PETROCHEMICAL CORPORATION (KR) | 2004-04-15 | — | — | US | claimed |
| EP-1363955-A1 | MULTINUCLEAR METALLOCENE CATALYST | Honam Petrochemical Corporation (KR) | 2003-11-26 | — | — | EP | claimed |
| WO-2002060964-A1 | MULTINUCLEAR METALLOCENE CATALYST | HONAM PETROCHEMICAL CORPORATION (KR) | 2002-08-08 | — | — | WO | claimed |
| CN-1331566-A | Game-type flavouring agent | NESTLE SA (CH) | 2002-01-16 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | PSMB11, PSMB5, PSMB6 | GABRA1 2805/4885GABRB2 2984/4885DAO 2725/4885 |
| US-20050215526-A1 | Melanin concentrating hormone receptor antagonist | MCHR1, MC1R, NPY1R | GABRA1 676/4885GABRB2 1002/4885DAO 624/4885 |
| US-10745372-B2 | Compound, resin, material for forming underlayer film for lithography, underlayer film for lithography, pattern forming method, and purification method | ASH2L, MLLT1, FRG1 | GABRA1 3852/4885GABRB2 4343/4885DAO 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.